Finance
Markets
No recent trading data. The last price we hold for ZBH is from Jun 3 (48 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

ZBH

stock
Zimmer Biomet
$84.98 +1.23 (+1.47%) Delayed · quoted 47d ago
Mixed 43% Slipping

What the indicators say

Mixed 1 of 5 trend signals bullish
Momentum · RSI 14 Neutral
50
0oversold 30overbought 70100

RSI 50 — momentum is balanced between buyers and sellers.

EMA 21 $84.43
Above
Near-term trend is up
SMA 50 $87.46
Below
Medium-term trend is down
SMA 200 $93.49
Below
Long-term trend is down
50 / 200-day
Death cross
50-day below the 200-day — bearish
Supertrend $88.43
Downtrend
Price is below the Supertrend band — bearish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range
Low $83.51 High $85.60
Open
$84.98
+1.47%
Close
$84.98
+1.47%
52-week range where the price sits across its year
52w low $79.12 52w high $108.29
Current
$84.98
Prev close
$83.75
Volume 0.84× the 3-month average
0 avg 2× avg
Today
1.95M
3-mo avg
2.31M

Earningscalendar synced from Yahoo 57d ago

Most recent
Apr 2884 days ago
Next expected
Jul 27in 6 days · estimated from cadence

Recent earnings dates

  • Apr 28 84 days ago
  • Feb 10 161 days ago
  • Nov 5, 2025 258 days ago
  • Aug 7, 2025 348 days ago

Past earnings dates come from ZBH’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 51d ago

Strong

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), ZBH’s fundamentals read as strong overall.

P/E ratio Strong
22.0x

At 22.0x, the price is a reasonable multiple of the company's annual profit.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair
1.13%

A 1.1% yield is modest: a small income on top of whatever the share price does.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Fair
8.6%

A 8.6% margin is solid, in the ordinary range for a profitable company.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Fair
5.6%

A 5.6% return on equity is respectable, in the normal range.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair
3.1%

A 3.1% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity Strong
0.82

At 0.82, the company carries less in liabilities than in equity, a conservative balance sheet.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Strong
1.98

At 1.98, short-term assets comfortably cover short-term bills.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair
+7.2%

Revenue grew 7.2% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Weak
-22.0%

Net income fell 22.0% from the prior year; profit is shrinking.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 51d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $6.8B$6.9B$7.4B$7.7B$8.2B
Net income $401.6M$231.4M$1.0B$903.8M$705.1M
Diluted EPS $1.91$1.10$4.88$4.43$3.55
Dividend / share $0.96$0.96$0.96$0.96$0.96
Total assets $23.5B$21.1B$21.5B$21.4B$23.1B
Total liabilities $10.8B$9.0B$9.0B$8.9B$10.4B
Shareholder equity $12.7B$12.0B$12.5B$12.5B$12.7B

Leadershipsynced from SEC 52d ago

  • Stellato Paul A VP, Controller, CAO
  • Bernard Betsy J Director
  • Farrell Michael J. Director
  • Hagemann Robert Director
  • Higgins Arthur J Director
  • Hilado Maria Teresa Director
  • Jafry Syed A. Director
  • Kolli Sreelakshmi Director
  • Kurdikar Devdatt Director
  • Shapiro Louis Director

Officers and board are drawn from ZBH’s recent SEC ownership filings (Forms 3, 4 and 5).

Recent leadership changes

Notable recent eventspast year

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Dividendssynced from Yahoo 52d ago

Pays quarterly Fair
2025 total
$0.96
2026 so far
$0.241 payment
2026 projected
$0.96+0.0% vs 2025

Projection scales ZBH’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.

Payment history

  • Mar 31 $0.24
  • Dec 30, 2025 $0.24
  • Sep 30, 2025 $0.24
  • Jun 26, 2025 $0.24
  • Mar 31, 2025 $0.24
  • Dec 30, 2024 $0.24
  • Sep 30, 2024 $0.24
  • Jun 26, 2024 $0.24
  • Mar 27, 2024 $0.24
  • Dec 26, 2023 $0.24
  • Sep 28, 2023 $0.24
  • Jun 23, 2023 $0.24
  • Mar 28, 2023 $0.24
  • Dec 23, 2022 $0.24
  • Sep 29, 2022 $0.24
  • Jun 24, 2022 $0.24
  • Mar 28, 2022 $0.24
  • Dec 27, 2021 $0.23
  • Sep 29, 2021 $0.23
  • Jun 25, 2021 $0.23

Recent SEC filingssynced from SEC 51d ago

© 2026 Isaac Bythewood · Some rights reserved